PT2729004T - Tratamento de acidúria metilmalónica, acidúria isovalérica, e outras acidúrias orgânicas com tocotrienol quinonas - Google Patents

Tratamento de acidúria metilmalónica, acidúria isovalérica, e outras acidúrias orgânicas com tocotrienol quinonas

Info

Publication number
PT2729004T
PT2729004T PT128077351T PT12807735T PT2729004T PT 2729004 T PT2729004 T PT 2729004T PT 128077351 T PT128077351 T PT 128077351T PT 12807735 T PT12807735 T PT 12807735T PT 2729004 T PT2729004 T PT 2729004T
Authority
PT
Portugal
Prior art keywords
acidúria
aciduries
tocotrienol
isovaleric
quinone
Prior art date
Application number
PT128077351T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Ptc Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Inc filed Critical Ptc Therapeutics Inc
Publication of PT2729004T publication Critical patent/PT2729004T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT128077351T 2011-07-06 2012-07-05 Tratamento de acidúria metilmalónica, acidúria isovalérica, e outras acidúrias orgânicas com tocotrienol quinonas PT2729004T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161505051P 2011-07-06 2011-07-06

Publications (1)

Publication Number Publication Date
PT2729004T true PT2729004T (pt) 2020-06-08

Family

ID=47437452

Family Applications (1)

Application Number Title Priority Date Filing Date
PT128077351T PT2729004T (pt) 2011-07-06 2012-07-05 Tratamento de acidúria metilmalónica, acidúria isovalérica, e outras acidúrias orgânicas com tocotrienol quinonas

Country Status (6)

Country Link
US (3) US20150057363A1 (OSRAM)
EP (1) EP2729004B1 (OSRAM)
JP (3) JP6728520B2 (OSRAM)
ES (1) ES2795798T3 (OSRAM)
PT (1) PT2729004T (OSRAM)
WO (1) WO2013006737A1 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2583087C (en) 2003-09-19 2012-07-10 Galileo Pharmaceuticals, Inc. Chroman derivatives
WO2006130775A2 (en) 2005-06-01 2006-12-07 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ， インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
EP3456707B1 (en) 2007-11-06 2020-04-15 PTC Therapeutics, Inc. 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EA023618B1 (ru) 2008-01-08 2016-06-30 Эдисон Фармасьютикалз, Инк. Производные (гет)арил-п-хинона для лечения митохондриальных болезней
CA2717734A1 (en) 2008-03-05 2009-09-11 Edison Pharmaceuticals, Inc 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases
WO2009158348A1 (en) 2008-06-25 2009-12-30 Edison Pharmaceuticals, Inc. 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
EP3827815B1 (en) 2008-09-10 2023-09-06 PTC Therapeutics, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
WO2010045220A1 (en) 2008-10-14 2010-04-22 Edison Pharmaceuticals, Inc. Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
TR201819154T4 (tr) 2008-10-28 2019-01-21 Bioelectron Tech Corp Alfa-tokotrienol kuinone ve ara ürünlerini içeren bileşim.
WO2010126911A1 (en) 2009-04-28 2010-11-04 Edison Pharmaceuticals, Inc. Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
US9464016B2 (en) 2011-06-14 2016-10-11 Edison Pharmaceuticals, Inc. Catechol derivatives for treatment of oxidative stress diseases
JP2014520894A (ja) 2011-07-19 2014-08-25 エジソン ファーマシューティカルズ， インコーポレイテッド 非アルファトコトリエノールの存在下でのアルファトコトリエノールの選択的酸化のための方法
CA2883882A1 (en) 2012-09-07 2014-03-13 Edison Pharmaceuticals, Inc. Benzoquinone derivatives for treating oxidative stress disorders
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
EP2970158B1 (en) 2013-03-15 2019-02-20 BioElectron Technology Corporation Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
EP3233786B1 (en) 2014-12-16 2022-03-16 PTC Therapeutics, Inc. Polymorphic and amorphous forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
EP3390377A1 (en) 2015-12-16 2018-10-24 BioElectron Technology Corporation Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
WO2017184583A1 (en) * 2016-04-19 2017-10-26 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Anaplerotic agents for treatment of disorders of propionate and long chain fat metabolism
JP2018083799A (ja) 2016-11-15 2018-05-31 バイオエレクトロン テクノロジー コーポレイション ２−置換アミノ−ナフト［１，２−ｄ］イミダゾール−５−オン化合物またはその製薬学上許容される塩
PL3866772T3 (pl) 2018-10-17 2024-04-08 Ptc Therapeutics, Inc. 2,3,5-trimetylo-6-nonylocykloheksa-2,5-dieno-1,4-dion do hamowania i leczenia alfa-synukleinopatii, tauopatii i innych zaburzeń
WO2020186216A1 (en) * 2019-03-14 2020-09-17 Hemoshear Therapeutics, Llc Methods of treating organic acidemias
CN114364664A (zh) * 2019-07-09 2022-04-15 伊卡根有限责任公司 Bcat调节
KR20240032997A (ko) 2021-07-08 2024-03-12 피티씨 테라퓨틱스, 인크. 2,3,5-트리메틸-6-노닐사이클로헥사-2,5-디엔-1,4-디온을 포함하는 약제학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204232D0 (en) 2002-02-22 2002-04-10 Isis Innovation Assay
ATE328283T1 (de) 2002-07-01 2006-06-15 Santhera Pharmaceuticals Ch Screeningverfahren und verbindungen zur behandlung von friedreich ataxia
US20080187911A1 (en) * 2003-01-30 2008-08-07 Research Development Foundation Methods and compositions for analysis of mitochondrial-related gene expression
WO2006130775A2 (en) * 2005-06-01 2006-12-07 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers
EP1749552A1 (en) * 2005-07-29 2007-02-07 Neuropharma S.A. Use of collismycin and derivatives thereof as oxidative stress inhibitors
WO2010126911A1 (en) * 2009-04-28 2010-11-04 Edison Pharmaceuticals, Inc. Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
WO2010126909A1 (en) * 2009-04-28 2010-11-04 Edison Pharmaceuticals, Inc. Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
WO2011072281A1 (en) * 2009-12-11 2011-06-16 Ptc Therapeutics, Inc. Methods for treating methylmalonic acidemia

Also Published As

Publication number Publication date
JP2014528914A (ja) 2014-10-30
EP2729004B1 (en) 2020-03-25
JP2020029465A (ja) 2020-02-27
WO2013006737A1 (en) 2013-01-10
EP2729004A1 (en) 2014-05-14
EP2729004A4 (en) 2014-11-19
US20210145769A1 (en) 2021-05-20
JP6728520B2 (ja) 2020-07-22
JP2018030892A (ja) 2018-03-01
US20150057363A1 (en) 2015-02-26
US20180303770A1 (en) 2018-10-25
ES2795798T3 (es) 2020-11-24

Similar Documents

Publication Publication Date Title
PT2729004T (pt) Tratamento de acidúria metilmalónica, acidúria isovalérica, e outras acidúrias orgânicas com tocotrienol quinonas
EP2864360A4 (en) TARGETED THERAPEUTICS
ZA201409215B (en) Macrocyclic inhibitors of flaviviridae viruses
IL236005A0 (en) Macrocyclic inhibitors of flavoviride viruses
IL236006A0 (en) Macrocyclic inhibitors of flavoviride viruses
EP2800590C0 (en) SLOTTED AND SIDE-OPENING CATHETER DEVICES
LT2885010T (lt) Tautopatijos gydymo būdai
CL2014003008A1 (es) Picolinamidas macróciclicas como fungicidas
EP4005507C0 (en) IMPLANT AND GUIDE
EP2663304A4 (en) COMBINATION THERAPY
BR112013019710A2 (pt) amortecedor rotativo
BR112015004370A2 (pt) composição esterilizada, processo de fabricação da mesma, utilização da mesma, e, kit
BR112013033974A2 (pt) terapia de combinação
FI20116007L (fi) Serotoniinitason nostaminen ja diagnostisointi
DK2760886T3 (da) Immunocytokin-kombinationsterapi
FI20115876A0 (fi) Yhdistelmähoito
EP2742033A4 (en) FLAVONOID COMPOUNDS AND METHODS OF USE
EP2682145A4 (en) SYRINGE AND SYRINGE ASSEMBLY
EP2919777A4 (en) TRANSMUCOSAL ADMINISTRATION OF TOCOTRIENOL
PT2750709T (pt) Tratamento da caquexia
BR112014006883A2 (pt) bactéria gram-positiva modificada e usos da mesma
EP2845854A4 (en) DEUTERIZED BENZOPYRANE CONNECTION AND APPLICATION THEREOF
EP2895186A4 (en) THERAPEUTIC COMPOSITIONS AND RELATED METHODS
EP2851085A4 (en) STERILIZED COMPOSITION
EP2807256A4 (en) MYONECTIN (CTRP15), COMPOSITION COMPRISING SAME AND METHODS OF USE